(Q38577755)

English

Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials

scientific article published on 31 August 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 September 2017

0 references

Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: a collaborative meta-analysis of randomized trials (English)

1 reference

Europe PubMed Central

4 September 2017

circulatory system

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

myocardial infarction

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Eugene Braunwald

13

object named as

Eugene Braunwald

1 reference

Europe PubMed Central

4 September 2017

Francesco Costa

object named as

Francesco Costa

6

0 references

object named as

Jacob A Udell

1

0 references

Marco Valgimigli

object named as

Marco Valgimigli

9

0 references

Gilles Montalescot

11

object named as

Gilles Montalescot

1 reference

Europe PubMed Central

4 September 2017

A Michael Lincoff

4

object named as

A Michael Lincoff

1 reference

Europe PubMed Central

4 September 2017

Deepak L. Bhatt

14

object named as

Deepak L Bhatt

1 reference

Europe PubMed Central

4 September 2017

Dean J Kereiakes

5

object named as

Dean J Kereiakes

1 reference

Europe PubMed Central

4 September 2017

8

object named as

Laura Mauri

1 reference

Europe PubMed Central

4 September 2017

Jean-Philippe Collet

3

object named as

Jean-Philippe Collet

1 reference

Europe PubMed Central

4 September 2017

2

object named as

Marc P Bonaca

1 reference

Europe PubMed Central

4 September 2017

Marc S Sabatine

12

object named as

Marc S Sabatine

1 reference

Europe PubMed Central

4 September 2017

author name string

Cheol Whan Lee

7

1 reference

Europe PubMed Central

4 September 2017

Seung-Jung Park

10

1 reference

Europe PubMed Central

4 September 2017

publication date

31 August 2015

1 reference

Europe PubMed Central

4 September 2017

European Heart Journal

1 reference

Europe PubMed Central

4 September 2017

37

1 reference

Europe PubMed Central

4 September 2017

4

1 reference

Europe PubMed Central

4 September 2017

390-399

1 reference

Europe PubMed Central

4 September 2017

Platelet hyperreactivity and prognosis in survivors of myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study).

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspective

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Late Consequences of Acute Coronary Syndromes: Global Registry of Acute Coronary Events (GRACE) Follow-up

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

One-year cardiovascular event rates in outpatients with atherothrombosis.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Antiplatelet and anticoagulation therapy for acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Long-term use of ticagrelor in patients with prior myocardial infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Short- versus long-term duration of dual-antiplatelet therapy after coronary stenting: a randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Impact of clinical presentation on ischaemic and bleeding outcomes in patients receiving 6- or 24-month duration of dual-antiplatelet therapy after stent implantation: a pre-specified analysis from the PRODIGY (Prolonging Dual-Antiplatelet Treatment

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Dual-antiplatelet treatment beyond 1 year after drug-eluting stent implantation (ARCTIC-Interruption): a randomised trial.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Benefits and Risks of Extended Duration Dual Antiplatelet Therapy After PCI in Patients With and Without Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Vorapaxar in the secondary prevention of atherothrombotic events

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Duration of dual antiplatelet therapy after drug-eluting stent implantation: a systematic review and meta-analysis of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Utilization of early invasive management strategies for high-risk patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

The risk of stent thrombosis in patients with acute coronary syndromes treated with bare-metal and drug-eluting stents.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

A prospective natural-history study of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Early and late effects of clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thro

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribu

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents: an observational study of drug-eluting versus bare-metal stents.

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

ISAR-SAFE: a randomized, double-blind, placebo-controlled trial of 6 vs. 12 months of clopidogrel therapy after drug-eluting stenting

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Clinical trial participation after myocardial infarction in a national cardiovascular data registry

1 reference

https://api.crossref.org/works/10.1093%2FEURHEARTJ%2FEHV443

21 January 2018

Identifiers

10.1093/EURHEARTJ/EHV443

1 reference

Europe PubMed Central

4 September 2017

1 reference

Europe PubMed Central

4 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38577755&oldid=2112377788"